Global Circulating Tumor Cell Market

Global Circulating Tumor Cell Market Size, Trends & Analysis - Forecasts To 2026 By Technology (CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis), By Product (Kits & Reagents, Blood Collection Tubes, Devices or Systems), By Application (Clinical/ Liquid Biopsy, Research), By Specimen (Bone Marrow, Blood, Other Body Fluids), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 16 2024 with the latest and most recent market numbers

Circulating Tumor Cell Market Size: Insights

The global circulating tumor cells market is estimated to witness a significant CAGR during the forecast period (2020-2026). Circulating tumor cells are the tumor cells that have shed from the primary tumor and circulated to the different parts of the body through the lymphatic system and blood circulation system and are useful for the diagnosis of cancer and to understand the disease progression. Growing demand for high Benefit-Cost Ratio (BCR) along with the adoption of CTCs technologies are some of the major factors driving the market growth during the forecast period. Increasing technological advancements in biomedical imaging and bioengineering, growing demand for minimally invasive diagnostic procedures, and increasing efficient application in intra and post-treatment drive the lucrative growth of the market. Moreover, the growing adoption of stem cell therapies is one of the significant factors driving market growth. However, lack of awareness among the population regarding various CTC technologies, and the stringent government regulations limits the growth of the market.

Circulating Tumor Cell Market Size: By Technology

Based on technology, the market is bifurcated into CTC detection & enrichment Methods, CTC analysis, and CTC direct detection methods. The enrichment method segment is expected to grow at a high CAGR during the forecast period. The growing consumer preference owing to the provision of better efficiency in detecting the CTCs is expected to drive the market growth. An efficient enrichment process tends to improve responsiveness, selectivity, and yield, thereby ensuring this field's productive clinical translation. The availability of different methods to enrich the circulating tumor cells in the detection of cancer is one of the significant factors driving the market growth.

Circulating Tumor Cell Market Size: By Application

Based on application, the global circulating tumor cell market is segmented into clinical/ liquid biopsy, and research. The clinical segment is expected to dominate the large share of the market during the forecast period owing to non-invasiveness and real-time advantages of circulating tumour cell screening, several companies, and research groups, and increasing initiatives by research groups in the market.

Circulating Tumor Cell Market Size: By Product

Based on product, the global circulating tumor cell market is segmented into kits & reagents, blood collection tubes, and devices or systems. The devices or systems segment is expected to hold the largest market share during the forecast period. The growing presence of a broad portfolio in this category, associated with long term microfluidic innovation technology is expected to drive the market growth.

Circulating Tumor Cell Market Size: By Region

Based on region, the global circulating tumor cell market is segmented into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. North America is projected to hold the largest market share during the forecast period due to the presence of healthcare infrastructure, technological advancements and skilled professionals among others. Moreover, rising initiatives by various companies and research firms to manufacture advanced technologies boost the growth of the market. Asia Pacific is also expected to grow at a high CAGR during the forecast period due to the increasing prevalence of cancer in various parts of China. Cancer is the foremost cause of death, with increasing mortality, in China, and is a major public health problem thus, driving the robust growth of the market. Growing patient awareness regarding early detection of cancer and risk assessment is one of the significant factors driving the market growth.

Circulating Tumor Cell Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase Circulating Tumor Cell. The key end-users of the markets are Mayo Clinic, Foothills Medical, and Human Longevity Inc., among others.

Circulating Tumor Cell Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Circulating Tumor Cell Market: Share & Competitor Analysis

Some of the key players operating in the circulating tumor cell market are QIAGEN, Bio-Techne Corporation, Advanced Cell Diagnostics, Inc., Precision for Medicine, ApoCell, Inc., Aviva Biosciences, BIOCEPT, INC., BioCep Ltd., Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., IVDiagnostics, Miltenyi Biotec, NanoString Technologies, Inc., BioFluidica, Canopus Bioscience Ltd., Biolidics Limited, Creatv MicroTech, Inc., LungLife AI, Inc., Epic Sciences, Rarecells Diagnostics, ScreenCell, Menarini Silicon Biosystems, Vitatex, Inc., Sysmex Corporation, and STEMCELL Technologies, Inc. among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In March 2018, Bio-Techne announced the expansion of the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays

Check the Press Release on Global Circulating Tumor Cell Market Report

Circulating Tumor Cell Market: By Technology

Introduction
1. Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
CTC Detection & Enrichment Methods
1. CTC Detection & Enrichment Methods: Circulating Tumor Cell Market, 2020-2026 (USD Million)
  1. Immunocapture (Label-based): Circulating Tumor Cell Market, 2020-2026 (USD Million)
  2. Size-based Separation (Label-free): Circulating Tumor Cell Market, 2020-2026 (USD Million)
  3. Density-based Separation (Label-free): Circulating Tumor Cell Market, 2020-2026 (USD Million)
  4. Combined Methods: Circulating Tumor Cell Market, 2020-2026 (USD Million)
CTC Direct Detection Methods
1. CTC Direct Detection Methods: Circulating Tumor Cell Market, 2020-2026 (USD Million)
  1. SERS: Circulating Tumor Cell Market, 2020-2026 (USD Million)
  2. Microscopy: Circulating Tumor Cell Market, 2020-2026 (USD Million)
  3. Others: Circulating Tumor Cell Market, 2020-2026 (USD Million)
CTC Analysis
1. CTC Analysis: Circulating Tumor Cell Market, 2020-2026 (USD Million)

Circulating Tumor Cell Market: By Product

Introduction
1. Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
Kits & Reagents
1. Kits & Reagents: Circulating Tumor Cell Market, 2020-2026 (USD Million)
Blood Collection Tubes
1. Blood Collection Tubes: Circulating Tumor Cell Market, 2020-2026 (USD Million)
Devices or Systems
1. Devices or Systems: Circulating Tumor Cell Market, 2020-2026 (USD Million)

Circulating Tumor Cell Market: By Application

Introduction
1. Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
Clinical/ Liquid Biopsy
1. Clinical/ Liquid Biopsy: Circulating Tumor Cell Market, 2020-2026 (USD Million)
Research
1. Research: Circulating Tumor Cell market, 2020-2026 (USD Million)

Circulating Tumor Cell Market: By Specimen

Introduction
1. Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
Bone Marrow
1. Bone Marrow: Circulating Tumor Cell Market, 2020-2026 (USD Million)
Blood
1. Blood: Circulating Tumor Cell Market, 2020-2026 (USD Million)
Other Body Fluids
1. Other Body Fluids : Circulating Tumor Cell Market, 2020-2026 (USD Million)

Circulating Tumor Cell Market: By Region

Introduction
1. Global Circulating Tumor Cell Market, Regional Analysis, 2020-2026 (USD Million)
North America
1. North America Circulating Tumor Cell Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Technology
    1. North America Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
  2. By Product
    1. North America Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
  3. By Application
    1. North America Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
  4. By Specimen
    1. North America Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
  5. By Country
    1. U.S
      1. By Technology
        
        U.S Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        U.S Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        U.S Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        U.S Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    2. Canada.
      1. By Technology
        
        Canada Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Canada Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Canada Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Canada Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    3. Mexico
      1. By Technology
        
        Mexico Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Mexico Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Mexico Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Mexico Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
Europe
1. Europe Circulating Tumor Cell Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Technology
    1. Europe Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
  2. By Product
    1. Europe Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
  3. By Application
    1. Europe Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
  4. By Specimen
    1. Europe Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
  5. By Country
    1. Germany
      1. By Technology
        
        Germany Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Germany Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Germany Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Germany Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    2. UK
      1. By Technology
        
        UK Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        UK Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        UK Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        UK Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    3. France
      1. By Technology
        
        France Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        France Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        France Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        France Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    4. Italy
      1. By Technology
        
        Italy Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Italy Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Italy Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Italy Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    5. Rest Of Europe
      1. By Technology
        
        Rest Of Europe Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Rest Of Europe Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Rest Of Europe Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Rest Of Europe Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
Asia Pacific
1. Asia Pacific Circulating Tumor Cell Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Technology
    1. Asia Pacific Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
  2. By Product
    1. Asia Pacific Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
  3. By Application
    1. Asia Pacific Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
  4. By Specimen
    1. Asia Pacific Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
  5. By Country
    1. China
      1. By Technology
        
        China Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        China Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        China Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        China Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    2. Japan
      1. By Technology
        
        Japan Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Japan Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Japan Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Japan Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    3. India
      1. By Technology
        
        India Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        India Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        India Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        India Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    4. South Korea
      1. By Technology
        
        South Korea Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        South Korea Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        South Korea Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        South Korea Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
Central & South America
1. Central & South America Circulating Tumor Cell Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Technology
    1. Central & South America Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
  2. By Product
    1. Central & South America Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
  3. By Application
    1. Central & South America Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
  4. By Specimen
    1. Central & South America Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
  5. By Country
    1. Brazil
      1. By Technology
        
        Brazil Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Brazil Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Brazil Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Brazil Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
Middle East & Africa
1. Middle East & Africa Circulating Tumor Cell Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Technology
    1. Middle East & Africa Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
  2. By Product
    1. Middle East & Africa Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
  3. By Application
    1. Middle East & Africa Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
  4. By Specimen
    1. Middle East & Africa Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
  5. By Country
    1. Saudi Arabia
      1. By Technology
        
        Saudi Arabia Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        Saudi Arabia Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        Saudi Arabia Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        Saudi Arabia Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)
    2. UAE
      1. By Technology
        
        UAE Circulating Tumor Cell Market, By Technology, 2020-2026 (USD Million)
      2. By Product
        
        UAE Circulating Tumor Cell Market, By Product, 2020-2026 (USD Million)
      3. By Application
        
        UAE Circulating Tumor Cell Market, By Application, 2020-2026 (USD Million)
      4. By Specimen
        
        UAE Circulating Tumor Cell Market, By Specimen, 2020-2026 (USD Million)

The global Circulating Tumor Cell Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Circulating Tumor Cell Market.

Circulating Tumor Cell Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Circulating Tumor Cell Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Circulating Tumor Cell Market